retatrutide phase 2 diabetes trial for weight loss: Study shows 30% body weight loss retatrutide nash trial Phase 2

In fact, several medical societies have issued statements advising against using compounded GLP-1 drugs outside of very specific shortage-related circumstances

What are the long-term effects of chronic pancreatitis on health

Changshu Hospital Affiliated to Soochow University, Changshu No.1 People's Hospital, Changshu 215500, Jiangsu Province, China

The addition of glucagon receptor activation increases energy expenditure directly, theoretically producing faster fat loss

It's also used to treat certain nerve-related conditions, such as optic neuropathy (damage to the optic nerve)

These are label statements, and they are presentation-specific in their details